Novak Biosciences Private Limited
About Novak Biosciences Private Limited
Data last updated:
Novak Biosciences Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 29 June 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24290UP2016PTC084475. Its GSTIN is 09AAFCN2712C1ZV (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Shiv Kumar Mittal and Manoj Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at F – 343 Phase – II Transport Nagar, Lucknow, Uttar Pradesh, India – 226012.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.42 Cr, a growth of 12% compared to the previous year. For the same year it recorded a net profit of ₹8.58 Lakh (net margin 1%) and EBITDA of ₹44.01 Lakh (EBITDA margin 5.2%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 11% over five years.
The company has about 24 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹1.1 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Novak Biosciences Private Limited's registered office is in Lucknow, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressF – 343 Phase – II Transport Nagar, Lucknow, Uttar Pradesh, India – 226012
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Novak Biosciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Novak Biosciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Novak Biosciences Private Limited, buy the company report.
Financials of Novak Biosciences Private Limited
FY 2025 filings availableNovak Biosciences Private Limited reported revenue of ₹8.42 Cr (up 12% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 12% growth in the latest year. EBITDA rose 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹44.01 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8.58 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.2% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Novak Biosciences Private Limited, buy the company report.
Board of directors of Novak Biosciences Private Limited
Novak Biosciences has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shiv Kumar Mittal | Director | 29 Jun 2016 | 10 Years 4 Months | Current |
| Manoj Kumar Also directs: Arushnova Pharmaceuticals Private Limited | Director | 29 Jun 2016 | 10 Years 4 Months | Current |
Auditor
Novak Biosciences Private Limited is audited by LATH & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| LATH & ASSOCIATES | FY 2019 | 001923C |
Shareholding
The shareholding of Novak Biosciences Private Limited is on record for 2 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Novak Biosciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Oct 2022 | 100628346 | Canara Bank | ₹15 Lakh | Open | |
| 21 Oct 2021 | 100510949 | Hdfc Bank Limited | ₹18.8 Lakh | Open | |
| 21 Oct 2021 | 100519822 | Hdfc Bank Limited | ₹18.8 Lakh | Open | |
| 19 Jun 2020 | 100355796 | Others | ₹7 Lakh | Open | |
| 30 Mar 2017 | 100093284 | Canara Bank | ₹50 Lakh | Open |
Total charge records: 5 View all charges
Legal cases
No court or tribunal cases involving Novak Biosciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Novak Biosciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Novak Biosciences Private Limited has a workforce of 24 employees on its EPFO records as of Apr 02, 2024, across 1 active EPFO establishment.
GST
Novak Biosciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAFCN2712C1ZV | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Novak Biosciences Private Limited, buy the company report.
Recent activity
Novak Biosciences Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Manoj Kumar was appointed as Director on 29 Jun 2016.
Frequently asked questions
Novak Biosciences is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 29 June 2016 (10+ years old) and is registered under CIN U24290UP2016PTC084475.
Novak Biosciences has 2 current directors:
- Shiv Kumar Mittal - Director
- Manoj Kumar - Director
The latest financial statements of Novak Biosciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Novak Biosciences is 09AAFCN2712C1ZV, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Novak Biosciences is U24290UP2016PTC084475. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Novak Biosciences was incorporated on 29 June 2016, making it 10+ years old. It is registered with the Registrar of Companies, Kanpur.
Manoj Kumar was appointed as Director on 29 Jun 2016. Shiv Kumar Mittal was appointed as Director on 29 Jun 2016.
The registered office of Novak Biosciences is at F – 343 Phase – II Transport Nagar, Lucknow, Uttar Pradesh, India – 226012.
Novak Biosciences operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Novak Biosciences has open charges of ₹1.1 Cr and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
